(R)-(−)-Xanthorrhizol Inhibits the Migration and Invasion of Triple-Negative Breast Cancer Cells by Suppressing Matrix Metalloproteinases via the NF-κB Signaling Pathway
Planta Medica · 01.08.2024 · 90 (10) · 785-791
DOI: 10.1055/a-2339-2633 ↗Kurz gefasst
Fachartikel in der Zeitschrift Planta Medica, erschienen am 01.08.2024. Verfasst von Mohammad Al-Amin und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Universiti Sains Malaysia, Pulau Pinang, Malaysia. Hauptthemen laut MEDLINE: NF-kappa B, Cell Movement, Signal Transduction, Xanthones. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 18 Literaturangaben. Gefördert von: Ministry of Higher Education Malaysia.
Abstract (Originalsprache)
(R)-(−)-xanthorrhizol is a bioactive sesquiterpenoid and major chemical constituent of Curcuma zanthorrhiza rhizomes. It was reported to have many pharmacological activities including nephroprotective, hepatoprotective, antimicrobial, anti-inflammatory, antioxidant, antihypertensive, antihyperglycemic, antiplatelet, estrogenic, and antiestrogenic properties. (R)-(−)-xanthorrhizol was also investigated for antiproliferative activity against many cancer cells including breast, lung, liver, ovarian, and colon cancer. It was also revealed to have a potential effect on TNBC cells MDA-MB-231. Considering the previous studies, this study has aimed to investigate the antimigratory and anti-invasive properties, as well as the possible molecular mechanisms, behind these properties. The findings of (R)-(−)-xanthorrhizol on MDA-MB-231 cell migration and invasion demonstrated significant inhibition at three different concentrations in a concentration-dependent manner, which was observed in the scratch, transwell migration, and invasion assays. Further investigation of the molecular mechanism using gelatin zymography revealed that (R)-(−)-xanthorrhizol prevented cell migration and invasion of breast cancer cells through the inhibition of matrix metalloproteinase-2 and matrix metalloproteinase-9 expression. Western blot analysis indicated that the inhibition of matrix metalloproteinases is possibly the result of the inhibition of phosphorylation in the NF-κB signaling pathway. These findings corroborate (R)-(−)-xanthorrhizol to proceed for the further studies as a possible future drug candidate for cancer patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Pharmaceutical Sciences, Universiti Sains Malaysia, Pulau Pinang, Malaysia.
- School of Chemical Sciences, Universiti Sains Malaysia, Pulau Pinang, Malaysia.
ORCID-Profile: Mohammad Al-Amin
Förderung
- Ministry of Higher Education Malaysia
Zitieren
APA
Al-Amin, M., Fazalul Rahiman, S. S., Khairuddean, M., & Muhamad Salhimi, S. (2024). (R)-(−)-Xanthorrhizol Inhibits the Migration and Invasion of Triple-Negative Breast Cancer Cells by Suppressing Matrix Metalloproteinases via the NF-κB Signaling Pathway. Planta Medica, 90(10), 785-791. https://doi.org/10.1055/a-2339-2633
Vancouver
Al-Amin M, Fazalul Rahiman SS, Khairuddean M, Muhamad Salhimi S. (R)-(−)-Xanthorrhizol Inhibits the Migration and Invasion of Triple-Negative Breast Cancer Cells by Suppressing Matrix Metalloproteinases via the NF-κB Signaling Pathway. Planta Medica. 2024;90(10):785-791. doi:10.1055/a-2339-2633
BibTeX
@article{AlAmin2024,
author = {Al-Amin, Mohammad and Fazalul Rahiman, Siti Sarah and Khairuddean, Melati and Muhamad Salhimi, Salizawati},
title = {(R)-(−)-Xanthorrhizol Inhibits the Migration and Invasion of Triple-Negative Breast Cancer Cells by Suppressing Matrix Metalloproteinases via the NF-κB Signaling Pathway},
journal = {Planta Medica},
year = {2024},
volume = {90},
number = {10},
pages = {785--791},
doi = {10.1055/a-2339-2633}
}
EUVIMED